Baird's Investment Banking Group is pleased to announce the following transaction:

Date:
June 2020
Company:
Calibre Scientific, Inc.
Description:
Secured Debt Financing
Sector(s):
Healthcare
Baird served as the exclusive debt advisor to Calibre Scientific, Inc. on this transaction

Calibre Scientific, Inc. (“Calibre Scientific” or the “Company”), the life sciences and diagnostics business owned by StoneCalibre, LLC (“StoneCalibre”), recently completed a recapitalization through a $92 million multicurrency first lien facility. The Company intends to use the proceeds to refinance the existing debt facility and to support its global acquisition strategy.

Founded in 2013, Calibre Scientific is a diversified global developer, manufacturer and distributor of consumable products in the life sciences and diagnostics markets. Since inception, the business has continually expanded through a combination of organic growth and acquisitions, and today has a broad portfolio of more than 3,000 products, which it sells into over 100 countries worldwide. Calibre Scientific’s 6,000+ customers include blue-chip biopharmaceutical companies, leading academic institutions and diagnostics companies.

StoneCalibre is a privately funded investment firm specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. StoneCalibre is headquartered in Los Angeles, California.

For additional information about this transaction, please contact:

Anne-Marie Peterson +1-646-557-2334
Ryan Mausehund +1-650-947-6817
Paul Bail +44-20-7667-8271
Eugene Weissberger +1-312-609-5434
Cameron Redifer +1-312-609-2561